Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132313) titled 'Study on tappering off TPO-RA by combination with cyclosporine' on Sept. 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Zhongshan Hospital, Fudan University
Condition:
Primary immune thrombocytopenia (ITP)
Intervention:
Control group:At enrollment, the patient continued to take the TPO-RA treatment dose.
Study group:At enrollment, patients continued to take the TPO-RA treatment dose
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-20
Target Sample Size: Control group:22;Study group:22;
Countries of Recruitment:
China
To know more, visi...